See other companies on Welcome to the Jungle
Better Therapeutics
Digital therapeutics for chronic diseases
- 21-100 employees
- Healthcare
- B2B
- Financial District, San Francisco, CA
Jump to section
Company mission
Better Therapeutics' mission is to make the benefits of lifestyle therapy accessible and affordable to everyone by creating new treatments to reverse the progression of disease.
58% employee growth in 12 months
Our take
Better Therapeutics offers a prescription digital therapeutics platform which leverages clinical, behavioral and psychological data to combat and prevent cardiometabolic diseases such as Type 2 Diabetes and Heart Disease.
The company’s behavior focused approach uses cognitive behavioral therapy as well as AI directed treatment based on data insights to ultimately rebuild underlying thought processes and actions which lead to complications with these diseases.
Even though modern medicine has made huge advances, it’s worrying that cardiometabolic diseases are rising, and healthcare costs in turn. Better Therapeutics' aim to turn this trend around by addressing the human causes behind it is a valuable one.
The company’s growth since 2015 has been impressive, but with the Digital Therapeutics market set to grow to over $13 billion by 2026, things are looking promising. 2021 looks like a turning point for Better, having now gone public at a valuation in the range of $200 million. This move was made possible since the company merged with Mountain Crest Acquisition Corp II, a deal which includes nearly $60 million in private investment intended to speed up growth.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- 401k retirement savings plan
- Access to our product for family members with qualifying conditions
- Competitive Salary, Bonus & 401k Retirement Savings Plan
- Participation in our Employee Stock Purchase Plan
- Health, Dental & Vision Benefits
- Personal Wellness & Work-from-Home Benefits
- Flexible Vacation Policy & Paid Parental Leave
- Recognition & Rewards Program
- Fully Distributed Company, Work remotely from anywhere in the United States
- Annual Team Retreat
- Modern & science-based people management practices aimed to unleash human potential, agility, and team collaboration
Funding (2 rounds)
Dec 2015
$21.8m
SERIES A
May 2015
$2m
SEED
Total funding: $23.8m
Leadership
Kevin Appelbaum
(CEO)Studied Chemical Engineering at Stanford, and was a Product Manager at P&G. Joined PepsiCo as Marketing Director of Pizza Hut in 1994, and was Senior VP of Sephora USA from 2006 to 2008. Was also CEO of Tria Beauty.
David Perry
(Chairman)Has an MBA from Harvard Business School. Started out as a Refinery Supervisor at Exxon, and then founded life-sciences company Chemdex. Co-founded Anacor Pharmaceuticals, and was CEO of agribusiness Indigo. Is also Director of Evelo Biosciences.